Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Isabel Brichette-Mieg"'
Autor:
Nicolás Lundahl Ciano-Petersen, Pablo Aliaga-Gaspar, Isaac Hurtado-Guerrero, Virginia Reyes, José Luis Rodriguez-Bada, Eva Rodriguez-Traver, Isabel Brichette-Mieg, Laura Leyva Fernández, Pedro Serrano-Castro, Ana Alonso, Begoña Oliver-Martos
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionNatalizumab is a biologic drug for relapsing-remitting multiple sclerosis that may induce the generation of anti-drug antibodies in some patients. Anti-natalizumab antibodies (ANA) increase the risk of adverse events and reduce efficacy,
Externí odkaz:
https://doaj.org/article/69a9e4df8ba44145a8f368bdc96332ab
Autor:
Pablo Aliaga-Gaspar, Isaac Hurtado-Guerrero, Nicolas Lundahl Ciano-Petersen, Patricia Urbaneja, Isabel Brichette-Mieg, Virginia Reyes, Jose Luis Rodriguez-Bada, Roberto Alvarez-Lafuente, Rafael Arroyo, Ester Quintana, Lluis Ramió-Torrentà, Ana Alonso, Laura Leyva, Oscar Fernández, Begoña Oliver-Martos
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
PurposeInterferon beta receptor 2 subunit (IFNAR2) can be produced as a transmembrane protein, but also as a soluble form (sIFNAR2) generated by alternative splicing or proteolytic cleavage, which has both agonist and antagonist activities for IFN-β
Externí odkaz:
https://doaj.org/article/5912837c529b4315bf6dcc4468e175fb
Autor:
Belén Delgado-Martín, Estefanía Caballano-Infantes, Carlos Sánchez-Gómez, Lorenzo G. Borrego, Isabel Brichette-Mieg, Daniel E. Di Zeo-Sánchez, Ana Dacil Marrero, Pablo Sánchez-Núñez, José Terrón-Bautista
Publikováno v:
EDULEARN Proceedings.
Autor:
Ana Dacil Marrero, Pablo Sánchez-Núñez, Estefanía Caballano-Infantes, Lorenzo G. Borrego, José Terrón-Bautista, Daniel E. Di Zeo-Sánchez, Isabel Brichette-Mieg, Belén Delgado-Martín, Carlos Sánchez-Gómez
Publikováno v:
EDULEARN Proceedings.
Autor:
Ana Grande-Pérez, Isabel Brichette-Mieg, Luis Díaz-Martínez, Axier Pineño-Ramos, Guillermo Domínguez-Huerta
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Lethal mutagenesis is an antiviral therapy that relies on increasing the viral mutation rate with mutagenic nucleoside or base analogues. Currently, the molecular mechanisms that lead to virus extinction through enhanced mutagenesis are not fully und